SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients

Kazem Vatankhah Yazdi,1 Seyed Mehdi Kalantar,1 Massoud Houshmand,2,3 Masoud Rahmanian,4 Masoud Reza Manaviat,5 Mohammad Reza Jahani,6 Behnam Kamalidehghan,2,7 Amir Almasi-Hashiani8 1Department of Genetic, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran; 2Department of...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Vatankhah Yazdi K, Kalantar SM, Houshmand M, Rahmanian M, Manaviat MR, Jahani MR, Kamalidehghan B, Almasi-Hashiani A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	type 2 diabetes mellitus (t2dm) iranian populations the tetra amplification refractory mutation system (arms) the genome-wide association studies (gwas) pharmacogenetics and pharmacogenomic Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/4762a33987e3497b99b9651c77919c14
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients

Ejemplares similares